托吡酯对比氟哌啶醇治疗儿童抽动秽语综合征的有效性和安全性Meta分析

郑子恢, 赵紫楠, 张亚同, 金鹏飞

中国药学杂志 ›› 2021, Vol. 56 ›› Issue (4) : 324-328.

PDF(1560 KB)
PDF(1560 KB)
中国药学杂志 ›› 2021, Vol. 56 ›› Issue (4) : 324-328. DOI: 10.11669/cpj.2021.04.012
论著

托吡酯对比氟哌啶醇治疗儿童抽动秽语综合征的有效性和安全性Meta分析

  • 郑子恢, 赵紫楠, 张亚同, 金鹏飞*
作者信息 +

A Meta Analysis of the Efficacy and Safety of Topiramate versus Haloperidol in the Treatment of Tourette Syndrome in Children

  • ZHENG Zi-hui, ZHAO Zi-nan, ZHANG Ya-tong, JIN Peng-fei*
Author information +
文章历史 +

摘要

目的 系统评价托吡酯与氟哌啶醇治疗儿童抽动秽语综合征(Gilles de la Tourette syndrome,GTS)的有效性和安全性,为临床治疗提供参考依据。方法 检索PubMed、Embase、中国知网、万方、维普等有关数据库,纳入评价托吡酯与氟哌啶醇治疗儿童GTS的随机对照试验(randomized controlled trial,RCT),检索时限从建库起至2020年9月。按纳入与排除标准筛选文献、提取资料并评价纳入研究的方法学质量后,采用Revman 5.4软件进行Meta分析。结果 共7项RCTs纳入分析,包括464例患者,试验组242例,对照组222例。年龄2.5~18岁。试验组患者使用药物为托吡酯,对照组患者使用药物为氟哌啶醇,使用耶鲁综合抽动严重程度量表(Yale Global Tie Severity Scale,YGTSS)评价有效性。Meta分析结果显示,两组YGTSS的严重度总评分差异有统计学意义(MD=-17.64,95%CI:-19.06~-16.21,P<0.01);两组不良反应发生率差异有统计学意义(RR=0.51,95%CI:0.34~0.75,P<0.01)。结论 托吡酯用于治疗GTS的有效性和安全性均优于氟哌啶醇。

Abstract

OBJECTIVE To systematically evaluate the efficacy and safety of topiramate versus haloperidol in the treatment of Gilles de la Tourette syndrome(GTS) in children, so as to provide references for the treatment of GTS. METHODS The databases of PubMed, Embase and CNKI were retrieved for randomized controlled trials (RCTS) evaluating topiramate versus haloperidol for TS in children starting from the establishment of the databases to September 2020. The Revman 5.4 software was used for Meta analysis after selecting the literature according to the inclusion and exclusion criteria, and extracting the data and evaluating the methodological quality of the included studie. RESULTS A total of 7 RCTs involving 464 patients of 2.5-18 years old were included with 242 patients in the experimental group administrating topiramate and 222 patients in the control group administrating haloperidol. The effectiveness was evaluated by the Yale Global Tie Severity Scale (YGTSS). Meta analysis results showed that the total severity scores of YGTSS in both groups were statistically significant (MD=-17.64, 95%CI:-19.06~-16.21, P<0.01). The total numbers of adverse reactions between both groups were statistically significant (RR=0.51, 95%CI: 0.34~0.75, P<0.01). CONCLUSION Topiramate is more effective and safe than haloperidol in the treatment of children with GTS.

关键词

托吡酯 / 氟哌啶醇 / 儿童 / 抽动秽语综合征 / Meta分析 / 随机对照试验

Key words

topiramate / haloperidol / children / Tourette's syndrome / Meta analysis / randomized controlled trial

引用本文

导出引用
郑子恢, 赵紫楠, 张亚同, 金鹏飞. 托吡酯对比氟哌啶醇治疗儿童抽动秽语综合征的有效性和安全性Meta分析[J]. 中国药学杂志, 2021, 56(4): 324-328 https://doi.org/10.11669/cpj.2021.04.012
ZHENG Zi-hui, ZHAO Zi-nan, ZHANG Ya-tong, JIN Peng-fei. A Meta Analysis of the Efficacy and Safety of Topiramate versus Haloperidol in the Treatment of Tourette Syndrome in Children[J]. Chinese Pharmaceutical Journal, 2021, 56(4): 324-328 https://doi.org/10.11669/cpj.2021.04.012
中图分类号: R965   

参考文献

[1] CHAI J B. Research and formulation of TCM clinical Diagnosis and treatment guidelines for tic disorders [C]. China Science Association People's Government of Jilin Province. 2017 Proceedings of the 19th China Association for Science and Technology Annual Conference, 2017:1-1.
[2] LI X. Research progress of multiple tics in children[J]. Med Recap(医学综述), 2012, 18(9):1352-1354.
[3] ZHENG W, ZHANG N, YANG J H, et al. Meta-analysis of children with tic disorder treated with topiramate and haloperidol[J]. Chin J Child Health(中国儿童保健杂志), 2015, 23(3):303-306.
[4] ZHANG H Y, LIN R, LIU M N, et al. Clonidine skin paster versus haloperidol and tiapride in the treatment of children with Tourette's syndrome[J]. J Pediatr Pharm(儿科药学杂志), 2006, 12(6):8-9.
[5] LIU W X, GUO Y Q. Observation on the effect of Tourette in the treatment of multiple tourette in children[J]. J Youjiang Med Coll Natl Minorities(右江民族医学院学报), 2006, 28(3):432-432.
[6] LIANG G A, YAO J F. Clinical observation of Tourette in the treatment of multiple tourette in children[J]. J Pract Med(实用医学杂志), 2010, 26(22):4192-4193.
[7] WANG G L, LI M L, CHEN B. Clinical study of topiramate in children with tic disorders[J]. Tianjin Pharm(天津药学), 2008, 20(6):52-53.
[8] ZHANG J Y, ZHOU J W, PAN J X. Clinical study of topiramate in the treatment of tourette disorder in children: efficacy and safety analysis of topiramate and haloperidol in the treatment of multiple tourette disease[J]. J Wenzhou Med Univ(温州医学院学报), 2006, 36(3):269-270.
[9] JANKOVIC J, JIMENEZ-SHAHED J, BROWN L W. A randomized, double-blind, placebo-controlled study of topiramate in the treatment of Toutette syndrome[J]. J Neurol Neur Psychiatr, 2010, 81(1):70-73.
[10] YANG C S, ZHANG L L, ZENG L N, et al. Topiramate for Toutette's syndrome in children: a Meta-analysisgy[J]. Pediatr Neurol, 2013, 49(5):344-350.
[11] The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. version 5.1.0[EB/OL]. [2019-04-26]. http://www.cochrane.org/.
[12] CHANG J, ZHAO H X, LI H B, et al. Value of topiramate in treating tourette syndrome[J]. Chin J Matern Child Health Care(中国妇幼保健), 2006, 21(9):1211-1213.
[13] ZHANG J J. Effect of topiramate on serum inflammatory factors in children with tic disorders and its therapeutic effect[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2013, 22(8):417-419.
[14] GAN R H. Clinical observation on the role of topiramate in the treatment of child Tourette's syndrome[J]. Heilongjiang Med J(黑龙江医学), 2012, 36(6):458-460.
[15] LU C, ZHANG W R. Clinical effect and safety of haloperidol combined with topiramate in the treatment of children with tic disorder[J]. China Pharm(中国药业), 2018, 27(14):53-56.
[16] CHEN S Z. Observation on the effect of topiramate on children with tic disorder[J]. China Health Care Nutr(中国保健营养), 2016, 26 (31):258-259.
[17] TAO R H, CHEN Y Y. Effect of topiramate in children with tic disorder and on plasma levels of glutamate and aspartate[J]. J Pediatr Pharm(儿科药学杂志), 2013, 19(6):21-23.
[18] HUANG Z M. Clinical observation of topiramate in treatment of intractable tourette disorder in children[J]. Jilin Med J(吉林医学), 2017, 38(8):1539-1540.
[19] Efficacy and safety of topiramate in the treatment of chronic tic disorders in children neurology Group, Chinese Pediatrics Society. Observation on the efficacy and safety of topiramate in the treatment of chronic tic disorders in children expert consensus on the diagnosis and treatment of tic disorders in children from the Neurology Group of Pediatrics Branch of Chinese Medical Association (Practical version 2017)[J]. Chin J Appl Clin Pediatr(中华实用儿科临床杂志), 2017, 32(15): 1137-1140.
[20] LU C, ZHANG W Y. Clinical effect and safety of haloperidol combined with topiramate in the treatment of children with tic disorder[J]. China Pharm(中国药业), 2018, 465(14): 59-62.
[21] Parkinson's disease and dyskinesia group, Chinese Neurology Branch, Chinese Medical Association. Guidelines for the diagnosis and treatment of Tourette syndrome[J]. Chin J Neurol(中华神经科杂志), 2009, 42(9):635-638.
[22] ZHU J. Comparison of the efficacy of valproate and haloperidol in the treatment of children with tic syndrome[J]. Chin Foreign Med Res(中外医学研究), 2020, 18(17):141-143.
[23] LÜ F. Systematic evaluation and study on the rule of traditional Chinese medicine in the treatment of multiple tourette's disease, [D]. Changsha: Hunan University of Chinese Medicine, 2018.
[24] ZHANG F C, YANG L. Clinical experience of dialectical treatment by differentiation of symptoms and signs for Tourette syndrome[J]. Chin Pediatr Integr Tradit Western Med(中国中西医结合儿科学), 2009, 1(2):113-115.
[25] ZHOU R Y, HAN X M, LEI S, et al. Efficacy of Anshen Dingzhiling Recipes in treating tourette syndrome[J]. Chin J Exp Tradit Med Form(中国实验方剂学杂志), 2016, 22(10):148-153.
[26] DING H L. Clinical study on treatment of children with attention deficit hyperactivity disorder by symptoms differentiation[J]. Acta Univ Tradit Med Sin Pharmacol Shanghai(上海中医药大学学报), 2014, 28(3): 43-46.
[27] DU C Y, HU S Y, ZHAO B J, et al. Clinical observation of Jiuwei Xifeng Granules in treatment of tic disorder in children with kidney-yin deficiency and liver-wind stirring[J]. Drugs Clin(现代药物与临床), 2017, 32(4):718-722.
[28] YOU D P. Contrast tesearch on Jiuweixifengkeli and haloperidol treat tic disorder[J]. J Dis Monitor Control(疾病监测与控制), 2017, 11:885-886.
[29] GAO C, WU Y L, WEI Y Q, et al.Effect observation of Jingling Oral liquid combined with haloperidol in treatment of Tourette syndrome in children[J]. Mod J Integr Tradit Chin Western Med(现代中西医结合杂志), 2019, 28(2):192-194.
[30] HUANG Y J, HE Y, ZHENG G, et al. Effect of Jingling Oral liquid combined with tiapride hydrochloride in the treatment of multiple tourette syndrome[J]. J Pract Med(实用医学杂志), 2014, 30(17):2847-2848.
[31] LU Y Q. Clinical effect observation of Duojingning capsule combined with Totai in treatment of multiple tourette disease in children[D]. Fuzhou: Fujian University of Traditional Chinese Medicine, 2012.
[32] SU H H. A Controlled study of the clinical effects of Duodongning capsule, Topiramate and Aripiprazole in the treatment of Tic Disorders[D]. Fuzhou:Fujian Medical University, 2015.
[33] WANG A M. Efficacy observation of antuogranule combined with tiopril in the treatment of Tourette syndrome in children[J]. Zhejiang J Integr Tradit Chin Western Med(浙江中西医结合杂志), 2016, 26(5):479-480, 486.
[34] COULTER D A, SOMBATI S, DELORENZO R J. Topiamate effects on excitatoryamino acid mediated responses in cultured hippocampalneurons:elective blockade of kainite currents[J]. Epilepsia, 1995, suppl 3:S40.
[35] JANKOVIC J, JIMENEZ-SHADED J, BROWN L W. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome[J]. J Neurol Neur Psychiatr, 2010, 81:70.
[36] YANG C S, ZHANG L L, ZENG L N, et al. Topiramate for Tourette's syndrome in children: a Meta-analysis[J]. Pediatr Neurol, 2013, 49:344.
[37] ZHU L P, YU R J. Observation on curative effect of Tourette syndrome treated with topiramate[J]. Heilongjiang Med J(黑龙江医学), 2011, 35(10):766-768.
PDF(1560 KB)

Accesses

Citation

Detail

段落导航
相关文章

/